MedTrace Logo

The Effect of Intrabdominal Pressure in Patients Undergoing Bariatric Surgery

NCT04929639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2021-06-18

No results posted yet for this study

Summary

Morbid obesity is a global health problem that concerns the whole world. It is associated with many concomitant health problems such as diabetes, hypertension, congestive heart failure. There are publications showing that morbid obesity increases chronic intra-abdominal pressure, and it has been investigated that this chronic pressure exposure may cause many comorbidities accompanying obesity. When we reviewed the literature, we could not find an adequate study showing the effects of obesity-related increased intra-abdominal pressure on postoperative mortality and morbidity.

The aim of this study is to show the effect of obesity-related intra-abdominal pressure on postoperative mortality and morbidity.

Conditions

  • Intraabdominal Pressure
  • Bariatrik Surgery

Interventions

OTHER

measurment of intraabdominal surgery

Immediately after intubation, while the patient is lying in the supine position, an intra-abdominal measurement will be made from the bladder catheter and recorded. Then, after the surgical site antisepsis, when the trocar required for the operation is placed by the general surgeon, another measurement will be made from the trocar port. Measurements will be recorded.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • MELIHA ORHON ERGUN · Marmara University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-05
Primary Completion
2020-06-05
Completion
2021-05-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929639 on ClinicalTrials.gov